Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Unknown × Temozolomide × Clear all

Phase

Phase 2 43 Phase 3 11 Phase 1/2 11 Phase 1 10 Phase NA 4 Phase 2/3 3 Phase EARLY_PHASE1 1

Status

Completed 3 Active not recruiting 3 Recruiting 2 Withdrawn 1 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 1

Interventions

fludarabine 15 Cyclophosphamide 14 Positron Emission Tomography Computed Tomography 4 Gemcitabine 4 68Ga-pentixafor 4 Oncolytic Virotherapy 3 Metformin 3 Melphalan 3 Immunotherapy, Adoptive 3 Cholestanetriol 26-Monooxygenase 3 toripalimab 2 pembrolizumab 2 lenvatinib 2 gallium Ga 68 dotatate 2 fludarabine phosphate 2 alpha-Synuclein 2 Radiotherapy 2 Radiosurgery 2 Pemetrexed 2 Paclitaxel 2 Nivolumab 2 Neoadjuvant Therapy 2 Magnetic Resonance Spectroscopy 2 Influenza Vaccines 2 Fluorodeoxyglucose F18 2 Cisplatin 2 Carboplatin 2 Bevacizumab 2 68Ga-NOTA-RM26 2 68Ga-FAPI 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03122197 2023-12-13

Study of Letrozole in Recurrent Gliomas

University of Cincinnati

Phase EARLY_PHASE1 Unknown

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡